Genic Co., Ltd. (KOSDAQ:123330)
33,400
-1,400 (-4.02%)
At close: Sep 3, 2026
Genic Revenue
Genic had revenue of 49.21B KRW in the quarter ending June 30, 2026, with 99.64% growth. This brings the company's revenue in the last twelve months to 114.29B, up 48.33% year-over-year. In the year 2025, Genic had annual revenue of 78.20B with 56.68% growth.
Revenue (ttm)
114.29B
Revenue Growth
+48.33%
P/S Ratio
2.18
Revenue / Employee
352.74M
Employees
324
Market Cap
249.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 78.20B | 28.29B | 56.68% |
| Dec 31, 2024 | 49.91B | 21.84B | 77.80% |
| Dec 31, 2023 | 28.07B | -3.38B | -10.74% |
| Dec 31, 2022 | 31.45B | -6.96B | -18.12% |
| Dec 31, 2021 | 38.41B | -3.72B | -8.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 772.05B |
| CLIO Cosmetics Co.,Ltd | 329.59B |
| C&C International | 292.76B |
| Englewood Lab | 218.19B |
| Icure Pharmaceutical Incorporation | 114.43B |
| Manyo Factory | 107.18B |
| BBIA Co., Ltd. | 77.16B |
| Bonne | 42.19B |